GlassScriptPhysician profile
Alex V Meneshian
NPI 1396706412
$4,919.33
in general payments reported to CMS, 2019-2025
12 companies · $67.46 in 2025
The $67.46 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $298 · 2021: $2,396 · 2022: $792 · 2023: $224 · 2024: $534 · 2025: $67.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684 · Education: $75.00 · Entertainment: $67.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.50 |
| Education | $75.00 |
| Entertainment | $67.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neoss, INC. | $2,019.44 | 2021-2022 | |
| Biohorizons Implant Systems INC. | $1,191.30 | 2020-2023 | Biohorizons |
| Keystone Dental INC. | $567.46 | 2024-2025 | |
| Dentsply Ih INC. | $370.00 | 2019 | |
| Zimvie INC. | $236.94 | 2022-2023 | |
| Allergan, INC. | $189.29 | 2019-2021 | |
| Dentsply Sirona INC | $101.75 | 2019-2020 | |
| Nobel Biocare USA | $65.88 | 2019-2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $57.17 | 2019-2021 | |
| Thommen Medical USA, LLC | $55.41 | 2021 | |
| Straumann USA LLC | $50.00 | 2022-2024 | |
| Geistlich Pharma, North America, INC. | $14.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Meneshian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.